Labshake search
Citations for Stemcell Technologies :
801 - 850 of 1595 citations for 1 Benzyl 4 5 benzyloxy 6 methoxy 1 indanone 2 ylidenyl methylpiperidine since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... and passaged every 3-4 days using ReLeSR (Stem Cell Technologies) until neural induction ...
-
bioRxiv - Neuroscience 2022Quote: ... and passaged every 3-4 days using ReLeSR (Stem Cell Technologies). Human iPSCs were edited for homozygous knockout of TAOK2 or heterozygous knock-in of the A135P mutation as described in Deneault et al.(Deneault et al. ...
-
bioRxiv - Microbiology 2023Quote: ... and 4 ug/mL Heparin sodium salt in PBS (StemCell Technologies) was replaced on the basolateral side only ...
-
bioRxiv - Cell Biology 2023Quote: ... Heparin 4 µg/mL (Ref 07980, Stemcell technologies, Saint Égrève, France) and Hydrocortisone 480 ng/mL (Ref 07925 ...
-
bioRxiv - Microbiology 2023Quote: ... and 4 ug/mL Heparin sodium salt in PBS (StemCell Technologies) was replaced on the basolateral side only ...
-
bioRxiv - Microbiology 2023Quote: ... and 4 µg/mL Heparin sodium salt in PBS (StemCell Technologies) was replaced on the basolateral side only ...
-
bioRxiv - Developmental Biology 2023Quote: ... Cells were split every 4 days using ReLeSR (STEMCELL Technologies Inc.) and plated 1×106 and 2×106 cells on Geltrex (Gibco ...
-
bioRxiv - Cell Biology 2024Quote: ... Cells were passaged every 4 days using ReLeSR media (StemCell Technologies) and were then seeded on a six-well Matrigel-coated plate at a density of 175,000 cells cm−2 in mTeSR-Plus medium ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 2 H3.1-K27M (GSC3, GSC4) cellular models were grown in NeurocultTM medium supplemented with heparin (2 μg/mL, Stemcell Technologies), EGF/FGF (20ng/mL ...
-
bioRxiv - Neuroscience 2021Quote: ... The cells were maintained on ESC-qualified Matrigel-coated 6-well plates in mTeSR plus medium (STEMCELL Technologies) with 10 μM Y-23632 (only for the initial 24 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... C57BL/6 CD8+ T cells were purified using the EasySep Mouse CD8 T Cell Isolation Kit (Stemcell technologies) according to the manufacturer’s instructions ...
-
bioRxiv - Neuroscience 2021Quote: ... the EB were transferred to a 6-well ultra-low adherent plate with Expansion Medium (Stem Cell Technologies). After 3 days ...
-
bioRxiv - Immunology 2022Quote: ... 1.1ml of the mixture was slowly distributed to a well in 6-well SmartDishTM plates (StemCell Technologies, 27370). 6-well plates were incubated in a 37°C ...
-
bioRxiv - Genomics 2021Quote: ... progenitor BM sorted cells were seeded (250 or 500 cells/well) into 6 well SmartDish™ (STEMCELL Technologies). After incubation for 14 days ...
-
bioRxiv - Cancer Biology 2020Quote: ... The tumors (6–8 mm in diameter) were mechanically dissociated and digested with collagenase/hyaluronidase (#07912, STEMCELL Technologies) containing DNase I (4 U/ml ...
-
bioRxiv - Immunology 2023Quote: ... or PEP-619WW C57BL/6 mice using a negative isolation kit (Stem Cell Technologies, Vancouver, British Columbia, Canada). A low number of isolated CD4 T cells ...
-
bioRxiv - Cell Biology 2023Quote: ... sorted cell populations were seeded (100 or 250 cells/well) into 6 well SmartDish™ (Stem Cell Technologies). After incubation for 14 days ...
-
bioRxiv - Synthetic Biology 2024Quote: ... Cells were seeded on Matrigel-coated 6-well plates (500,000 cells per plate) in mTeSR1 medium (Stemcell Technologies) with doxycycline (1 µg/mL ...
-
bioRxiv - Neuroscience 2024Quote: ... Approximately 3 × 10^6 cells were placed in each well of an AggreWell 800 plate (STEMCELL Technologies # 34811) containing Stemflex medium enriched with 1X Revita supplement ...
-
bioRxiv - Cancer Biology 2020Quote: ... heparin (2 μg/ml; Stem Cell Tech, #07980), and Antibiotic-Antimycotic solution (0.1% ...
-
bioRxiv - Genetics 2022Quote: ... 2 μM doxycycline and CloneR supplement (StemCell Technologies) to enhance the viability of single cells ...
-
bioRxiv - Neuroscience 2020Quote: ... and heparin (2 μg/mL, StemCell Technologies, #07980).
-
bioRxiv - Cancer Biology 2020Quote: ... 2 μg/mL Heparin (Stem Cell Technologies #07980) and L-glutamine (2mM ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 2% NeuroCult SM1 supplement (STEMCELL Technologies) and 1% penicillin/streptomycin (Gibco) ...
-
bioRxiv - Cell Biology 2021Quote: ... containing 2% NeuroCult SM1 supplement (StemCell Technologies, 05711), 1% L-glutamine (Corning ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980). All cultures were used within the first 20 passages of generation ...
-
bioRxiv - Immunology 2020Quote: ... with 2 mL Spleen Dissociation Medium (STEMCELL Technologies) and homogenized using the Miltenyi GentleMacs dissociator ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980); 500 μL of 25% BSA (Millipore-Sigma ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (Stem Cell Technologies), as previously described (Tominaga et al. ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µM of XAV939 (STEMCELL Technologies, #72674) were added to induce cerebro-cortical differentiation ...
-
bioRxiv - Neuroscience 2022Quote: ... 2 mL of ReLeSR (StemCell Technologies, cat.no. 05872) solution was applied for 30 seconds at room temperature ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 μM of XAV939 (#72674, StemCell Technologies). The medium was changed daily until day 11 ...
-
bioRxiv - Immunology 2022Quote: ... and/or rat serum (2%; Stem Cell Technologies) for 5min on ice prior to adding fluorescent antibodies (BioLegend ...
-
bioRxiv - Neuroscience 2023Quote: ... 2% NeuroCult™ SM1 (STEMCELL Technologies, Cat# 05711), 1% N-2 Supplement (Thermo Scientific ...
-
bioRxiv - Cancer Biology 2023Quote: ... 2×105 hDR4+ HSCs (purchased from Stemcell Technologies Inc ...
-
bioRxiv - Bioengineering 2023Quote: ... and 10 μMY27632 (Stemcell Technologies, 129830-38-2)) on day 0 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 100 ng/mL IGF-2 (STEMCELL Technologies #78023), and 10 μM Y-27632 (STEMCELL Technologies #72308 ...
-
bioRxiv - Cell Biology 2024Quote: ... we performed a Cut and Run/Q-PCR (C&R/Q-PCR) experiment of 5×105 untreated cells and 5×105 cells treated for 30 minutes with recombinant human INFγ (STEMCELL Technologies, Vancouver, BC, Canada). For the C&R procedure ...
-
bioRxiv - Microbiology 2020Quote: ... and 5 µM A83-01 (all from Stem Cell Technologies). Expansion media was replaced every 3-4 days ...
-
bioRxiv - Cell Biology 2021Quote: ... 5% CO2 (MegaCult®-C Medium without Cytokines, STEMCELL Technologies). Cultures were supplemented with human recombinant 50 ng/ml TPO (Peprotech) ...
-
bioRxiv - Cancer Biology 2024Quote: ... and resuspended in 5 U/mL dispase (StemCell Technologies, 07913) with 0.1 mg/mL DNase I (Sigma-Aldrich ...
-
bioRxiv - Biochemistry 2023Quote: ... Doxycycline (Cas No.24390-14-5) from Stem Cell Technologies, and SGK1 inhibitor GS-9007 (Cas No.1426214-51-8 ...
-
bioRxiv - Cell Biology 2023Quote: ... followed by 5 U/ml dispase (Stem Cell Technologies, 07913) and 50 ug/ml DNase I (Sigma ...
-
bioRxiv - Bioengineering 2024Quote: ... the cells were treated with 5 µM Ionomycin (STEMCELL Technologies). hHOs were generated from hiPSC-L1 ...
-
bioRxiv - Neuroscience 2021Quote: ... placed in a stereotaxic frame and injected with either 100,000 hNSCs per side (2 μl/injection) or vehicle (2 μl HBSS with 20 ng/ml epidermal growth factor [STEMCELL Technologies, #78003] and human fibroblast growth factor [STEMCELL ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were centrifuged at 200 x g for 2 min and resuspended in neural media (NM; Supplementary Table 2) supplemented with 0.02 µg/mL FGF2 (StemCell Technologies, #78003) and 0.02 µg/mL EGF (StemCell Technologies ...
-
IRF1 regulates self-renewal and stress-responsiveness to support hematopoietic stem cell maintenancebioRxiv - Cell Biology 2023Quote: ... Briefly, PB was collected in FACS buffer (PBS, 2 % FBS, 2 mM EDTA) supplemented with 0.0004 % heparin solution (STEMCELL Technologies Inc.). RBCs was removed by incubation at 37 °C for 25 minutes with 1 % Dextran solution in PBS ...
-
bioRxiv - Genetics 2024Quote: ... Contractile VSMCs were then induced with N2B27 supplemented with 2 ng/ml Activin A and 2 µg/ml Heparin (STEMCELL Technologies) for 5 days ...
-
bioRxiv - Genomics 2024Quote: ... Contractile VSMCs were subsequently induced by culturing in N2B27 medium containing 2 ng/ml Activin A and 2 µg/ml Heparin (STEMCELL Technologies) for 6 days ...
-
bioRxiv - Bioengineering 2021Quote: ... Cells were counted using a haemocytometer and seeded in mTeSR™1 (STEMCELL Technologies, 85850) and a density of 5×105 cells/ml as a 1ml/well solution in a 12-well culture dish with 10uM Rock inhibitor Y27632 (ATCC® ACS-3030™) ...